Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2851751 | American Heart Journal | 2008 | 6 Pages |
Abstract
Concomitant AR at the time of PMV does not influence procedural success and is not associated with inferior outcome. A minority of patients with MS and moderate AR who undergo PMV will require subsequent AVR on long-term follow-up. Thus, patients with rheumatic MS and mild to moderate AR remain good candidates for PMV.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Maria MD, Ignacio MD, PhD, Pedro L. MD, PhD, Javier MD, Hani MD, Pablo MD, Roberto J. MD, Ignacio MD, Andrew O. MD, Igor F. MD,